Stratos Wealth Partners, Ltd. Adamis Pharmaceuticals Corp Transaction History

Stratos Wealth Partners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$2.1 - $3.21 $9,660 - $14,766	-4,600 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$2.25 - $4.8 $10,350 - $22,080	4,600 New	4,600 $16,000
Q2 2018 Aug 13, 2018	SELL	$3.2 - $4.7 $800 - $1,175	-250 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$2.55 - $4.85 $637 - $1,212	250 New	250 $1,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.